Research output per year
Research output per year
Fingerprint
Dive into the research topics where Medical retina and Uveitis is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
Long-Term Safety and Efficacy of Adalimumab in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis
Suhler, E. B., Jaffe, G. J., Fortin, E., Lim, L. L., Merrill, P. T., Dick, A. D., Brezin, A. P., Nguyen, Q. D., Thorne, J. E., Van Calster, J., Cimino, L., Adan, A., Goto, H., Kaburaki, T., Kramer, M., Vitale, A. T., Kron, M., Song, A. P., Liu, J., Pathai, S. & 6 others, , Jun 2021, In: Ophthalmology. 128, 6, p. 899-909 11 p.Research output: Contribution to journal › Article › Research › peer-review
-
Defining inclusion criteria and endpoints for clinical trials: a prospective cross-sectional study in CRB1-associated retinal dystrophies
Talib, M., van Schooneveld, M. J., Wijnholds, J., van Genderen, M. M., Schalij-Delfos, N. E., Talsma, H. E., Florijn, R. J., ten Brink, J. B., Cremers, F. P. M., Thiadens, A. A. H. J., van den Born, L. I., Hoyng, C. B., Meester-Smoor, M. A., Bergen, A. A. & Boon, C. J. F., May 2021, In: Acta Ophthalmologica. 99, 3, p. e402-e414Research output: Contribution to journal › Article › Research › peer-review
-
BBS1 branchpoint variant is associated with non-syndromic retinitis pigmentosa
Fadaie, Z., Whelan, L., Dockery, A., Li, C. H. Z., van der Born, L. I., Hoyng, C. B., Gilissen, C., Corominas, J., Rowlands, C., Megaw, R., Lampe, A. K., Cremers, F. P. M., Farrar, G. J., Ellingford, J. M., Kenna, P. F. & Roosing, S., 28 Apr 2021, (E-pub ahead of print) In: Journal of Medical Genetics.Research output: Contribution to journal › Article › Research › peer-review
Press / Media
-
Eerste gentherapie bij oogheelkundig patiënt in Nederland uitgevoerd in Het Oogziekenhuis Rotterdam
Ingeborgh van den Born & Koen van Overdam
15/03/21 → 2/04/21
4 items of Media coverage, 6 Media contributions
Press/Media
-
Gentherapie voor zeldzame oogziekte vergoed
29/12/20 → 3/01/21
2 items of Media coverage, 2 Media contributions
Press/Media
-